Published in Int J Infect Dis on September 01, 2005
IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity. Science (2017) 2.10
Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens. PLoS One (2009) 1.72
Dengue virus evolution and virulence models. Clin Infect Dis (2007) 1.64
Diabetes with hypertension as risk factors for adult dengue hemorrhagic fever in a predominantly dengue serotype 2 epidemic: a case control study. PLoS Negl Trop Dis (2012) 1.29
Cytokine expression profile of dengue patients at different phases of illness. PLoS One (2012) 1.28
Dengue: where are we today? Malays J Med Sci (2009) 1.10
Acute kidney injury in dengue virus infection. Clin Kidney J (2012) 1.08
Dengue expansion in Africa-not recognized or not happening? Emerg Infect Dis (2014) 1.03
Understanding the dengue viruses and progress towards their control. Biomed Res Int (2013) 1.02
The complexity of antibody-dependent enhancement of dengue virus infection. Viruses (2010) 0.99
A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease. J Virol (2014) 0.99
Why are people with dengue dying? A scoping review of determinants for dengue mortality. BMC Infect Dis (2015) 0.95
Fatal dengue in patients with sickle cell disease or sickle cell anemia in Curaçao: two case reports. PLoS Negl Trop Dis (2013) 0.93
Predictors of hospital stay and mortality in dengue virus infection-experience from Aga Khan University Hospital Pakistan. BMC Res Notes (2014) 0.85
Simulations to compare efficacies of tetravalent dengue vaccines and mosquito vector control. Epidemiol Infect (2013) 0.83
Variation in inflammatory/regulatory cytokines in secondary, tertiary, and quaternary challenges with dengue virus. Am J Trop Med Hyg (2012) 0.78
Signaling by Antibodies: Recent Progress. Annu Rev Immunol (2017) 0.76
Diabetes, cardiac disorders and asthma as risk factors for severe organ involvement among adult dengue patients: A matched case-control study. Sci Rep (2017) 0.75
The Role and Function of Fcγ Receptors on Myeloid Cells. Microbiol Spectr (2016) 0.75
Dengue: an update. Lancet Infect Dis (2002) 9.02
Functional atlas of emotional faces processing: a voxel-based meta-analysis of 105 functional magnetic resonance imaging studies. J Psychiatry Neurosci (2009) 4.16
Effect of age on outcome of secondary dengue 2 infections. Int J Infect Dis (2002) 3.77
Dengue diagnosis, advances and challenges. Int J Infect Dis (2004) 3.14
Multicentre prospective study on dengue classification in four South-east Asian and three Latin American countries. Trop Med Int Health (2011) 2.60
Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis. PLoS Negl Trop Dis (2010) 2.33
ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria. Cell Microbiol (2012) 1.99
Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. Rev Panam Salud Publica (2002) 1.75
Brain anatomy and development in autism: review of structural MRI studies. Brain Res Bull (2003) 1.74
Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis. Neurosci Biobehav Rev (2007) 1.67
Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacol Rev (2006) 1.51
IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba. J Med Virol (2004) 1.50
Neutralizing antibodies after infection with dengue 1 virus. Emerg Infect Dis (2007) 1.33
A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates. Vaccine (2006) 1.24
Optical coherence tomography of laryngeal cancer. Laryngoscope (2006) 1.23
Brain anatomy of persistent violent offenders: more rather than less. Psychiatry Res (2008) 1.17
PCR detection of dengue virus using dried whole blood spotted on filter paper. J Virol Methods (2005) 1.14
Dengue 3 epidemic, Havana, 2001. Emerg Infect Dis (2004) 1.10
[Dengue and dengue hemorrhagic fever: research priorities]. Rev Panam Salud Publica (2006) 1.09
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients. Eur Neuropsychopharmacol (2006) 1.06
Optical coherence tomography of the newborn airway. Ann Otol Rhinol Laryngol (2008) 1.02
Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates. Antiviral Res (2008) 1.00
Optical coherence tomography of the larynx in the awake patient. Otolaryngol Head Neck Surg (2008) 1.00
Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients. J Affect Disord (2006) 1.00
The complexity of antibody-dependent enhancement of dengue virus infection. Viruses (2010) 0.99
Primary and secondary infections of Macaca fascicularis monkeys with Asian and American genotypes of dengue virus 2. Clin Vaccine Immunol (2007) 0.97
Gradient-index lens rod based probe for office-based optical coherence tomography of the human larynx. J Biomed Opt (2009) 0.97
Ethnicity and difference in dengue virus-specific memory T cell responses in Cuban individuals. Viral Immunol (2006) 0.95
Alexithymia in healthy women: a brain morphology study. J Affect Disord (2008) 0.94
Gln145Met/Leu changes in human immunodeficiency virus type 1 reverse transcriptase confer resistance to nucleoside and nonnucleoside analogs and impair virus replication. Antimicrob Agents Chemother (2004) 0.94
Amino acid changes in the recombinant Dengue 3 Envelope domain III determine its antigenicity and immunogenicity in mice. Virus Res (2006) 0.94
West Nile Virus infection in humans and horses, Cuba. Emerg Infect Dis (2006) 0.94
Fatal severe dengue and cell death in sickle cell disease during the 2001-2002 Havana dengue epidemic. Int J Infect Dis (2008) 0.93
Anamnestic antibody response after viral challenge in monkeys immunized with dengue 2 recombinant fusion proteins. Arch Virol (2008) 0.93
Corticostriatal brain-derived neurotrophic factor dysregulation in adult rats following prenatal stress. Eur J Neurosci (2004) 0.92
Interactions between TonB from Escherichia coli and the periplasmic protein FhuD. J Biol Chem (2006) 0.92
Chronic antidepressants induce redistribution and differential activation of alphaCaM kinase II between presynaptic compartments. Neuropsychopharmacology (2007) 0.90
Humoral immune response of dengue hemorrhagic fever cases in children from Tegucigalpa, Honduras. Am J Trop Med Hyg (2008) 0.90
Dogma in classifying dengue disease. Am J Trop Med Hyg (2013) 0.89
Association between the G1001C polymorphism in the GRIN1 gene promoter region and schizophrenia. Biol Psychiatry (2003) 0.89
Prophylactic platelets in dengue: survey responses highlight lack of an evidence base. PLoS Negl Trop Dis (2012) 0.89
Characterization of dengue shock syndrome in pediatric patients in El Salvador. Pediatr Infect Dis J (2011) 0.88
[A community education strategy to promote participation in dengue prevention in Cuba]. Rev Panam Salud Publica (2008) 0.88
Neuroimaging and electrophysiological studies of the effects of acute tryptophan depletion: a systematic review of the literature. Psychopharmacology (Berl) (2006) 0.88
CYP2C19 genotype predicts steady state escitalopram concentration in GENDEP. J Psychopharmacol (2011) 0.87
Pandemic influenza A (H1N1) 2009 with neurological manifestations, a case series. Influenza Other Respir Viruses (2010) 0.87
Induction of neutralizing antibodies and partial protection from viral challenge in Macaca fascicularis immunized with recombinant dengue 4 virus envelope glycoprotein expressed in Pichia pastoris. Am J Trop Med Hyg (2003) 0.87
Engineered covalent leucotoxin heterodimers form functional pores: insights into S-F interactions. Biochem J (2006) 0.87
Epidemiological studies on dengue virus type 3 in Playa municipality, Havana, Cuba, 2001-2002. Int J Infect Dis (2012) 0.87
Oxidative stress in adult dengue patients. Am J Trop Med Hyg (2004) 0.87
A myocarditis outbreak with fatal cases associated with adenovirus subgenera C among children from Havana City in 2005. J Clin Virol (2008) 0.86
AKAP149 binds to HIV-1 reverse transcriptase and is involved in the reverse transcription. J Mol Biol (2008) 0.86
Secondary heterologous dengue infection risk: Disequilibrium between immune regulation and inflammation? Cell Immunol (2010) 0.86
Dengue, one of the great emerging health challenges of the 21st century. Expert Rev Vaccines (2004) 0.85
[Final characterization of and lessons learned from the dengue 3 epidemic in Cuba, 2001-2002]. Rev Panam Salud Publica (2006) 0.85
Association between urinary albumin excretion and both central and peripheral blood pressure in subjects with insulin resistance. J Hypertens (2013) 0.85
Quetiapine regulates FGF-2 and BDNF expression in the hippocampus of animals treated with MK-801. Neuroreport (2004) 0.85
First report on fatal myocarditis associated with adenovirus infection in Cuba. J Med Virol (2008) 0.85
Dengue vaccine: priorities and progress. Expert Rev Anti Infect Ther (2004) 0.85
[Quality control of the serological diagnosis of dengue in laboratories throughout the Americas, 1996-2001]. Rev Panam Salud Publica (2003) 0.85
[Dengue, a growing problem of health in the Americas]. Rev Panam Salud Publica (2006) 0.85
Parallel solution-phase and microwave-assisted synthesis of new S-DABO derivatives endowed with subnanomolar anti-HIV-1 activity. J Med Chem (2005) 0.85
Discovery of non-nucleoside inhibitors of HIV-1 reverse transcriptase competing with the nucleotide substrate. Angew Chem Int Ed Engl (2007) 0.84
Population structure of the dengue viruses, Aragua, Venezuela, 2006-2007. Insights into dengue evolution under hyperendemic transmission. Infect Genet Evol (2011) 0.84
Recruitment and membrane interactions of host cell proteins during attachment of enteropathogenic and enterohaemorrhagic Escherichia coli. Biochem J (2012) 0.83
Dual infection with dengue virus 3 and human immunodeficiency virus 1 in Havana, Cuba. J Infect Dev Ctries (2009) 0.83
Regarding "Dengue--how best to classify it". Clin Infect Dis (2012) 0.83
Association between IL-1beta -511C/T and IL-1RA (86bp)n repeats polymorphisms and schizophrenia. J Psychiatr Res (2003) 0.82
An association of GRIK3 Ser310Ala functional polymorphism with personality traits. Neuropsychobiology (2009) 0.81
In vitro evaluation of endotracheal tubes with intrinsic suction. Chest (2010) 0.81
Association study of -1727 A/T, -50 C/T and (CAA)n repeat GSK-3beta gene polymorphisms with schizophrenia. Neuropsychobiology (2004) 0.81
The functional neuroanatomy of autism. Funct Neurol (2004) 0.80
Protein kinase A activity in platelets from patients with bipolar disorder. J Affect Disord (2003) 0.80
Dopaminergic D2 receptor activation modulates FGF-2 gene expression in rat prefrontal cortex and hippocampus. J Neurosci Res (2003) 0.80
Metallothionein concentration in the mussel Mytilus galloprovincialis as a biomarker of response to metal contamination: validation in the field. Biomarkers (2003) 0.80
Dengue in Cuba: research strategy to support dengue control. Lancet (2009) 0.79
Structural and functional properties of chimeric EspA-FliCi filaments of EPEC. J Mol Biol (2008) 0.79
WHO dengue case classification 2009 and its usefulness in practice: an expert consensus in the Americas. Pathog Glob Health (2015) 0.79
Virus role during intraepidemic increase in dengue disease severity. Vector Borne Zoonotic Dis (2011) 0.79
Synthesis and biological investigation of S-aryl-S-DABO derivatives as HIV-1 inhibitors. Bioorg Med Chem Lett (2006) 0.78
The fusion site of envelope fragments from each serotype of Dengue virus in the P64k protein, influence some parameters of the resulting chimeric constructs. Biochem Biophys Res Commun (2003) 0.78
Prevalence of febrile syndromes in dengue surveillance, havana city, 2007. MEDICC Rev (2011) 0.78
Clinical characteristics in long-term care psychiatric patients: a descriptive study. World J Biol Psychiatry (2009) 0.78
N2-benzyloxycarbonylguan-9-yl acetic acid derivatives as HIV-1 reverse transcriptase non-nucleoside inhibitors with decreased loss of potency against common drug-resistance mutations. ChemMedChem (2007) 0.77
Selective targeting of the HIV-1 reverse transcriptase catalytic complex through interaction with the "primer grip" region by pyrrolobenzoxazepinone non-nucleoside inhibitors correlates with increased activity towards drug-resistant mutants. Biochem Pharmacol (2008) 0.77
NNRTI-selected mutations at codon 190 of human immunodeficiency virus type 1 reverse transcriptase decrease susceptibility to stavudine and zidovudine. Antiviral Res (2007) 0.77
Correlation between the dioptric power, astigmatism and surface shape of the anterior and posterior corneal surfaces. Ophthalmic Physiol Opt (2009) 0.76
The protein kinase A in platelets from patients with panic disorder. Eur Neuropsychopharmacol (2002) 0.76
Selective serotonin reuptake inhibitors (SSRIs) and depression after myocardial infarction (MI). J Psychiatry Neurosci (2005) 0.76
Effects of drug resistance mutations L100I and V106A on the binding of pyrrolobenzoxazepinone nonnucleoside inhibitors to the human immunodeficiency virus type 1 reverse transcriptase catalytic complex. Antimicrob Agents Chemother (2004) 0.75
Changes in signaling pathways regulating neuroplasticity induced by neurokinin 1 receptor knockout. Eur J Neurosci (2005) 0.75
Drug resistance mutations in the nucleotide binding pocket of human immunodeficiency virus type 1 reverse transcriptase differentially affect the phosphorolysis-dependent primer unblocking activity in the presence of stavudine and zidovudine and its inhibition by efavirenz. Antimicrob Agents Chemother (2005) 0.75
Time-course changes in rat cerebral cortex subcellular distribution of the cyclic-AMP binding after treatment with selective serotonin reuptake inhibitors. Int J Neuropsychopharmacol (1998) 0.75
Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 1). ChemMedChem (2006) 0.75